Skip to content

Medical-device intelligence

MZP: Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus

FDA product code MZP: Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
MZP
FDA device name
Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
Device class
2
Regulation number
866.3170
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

4 clearance records and 11 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from Jul 7, 2004 to Nov 3, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202510
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

15 matching records
Device / recordCompany in FDA recordSourceSource date
cobas HCVK252484 · MZPRoche Molecular Systems, Inc.510(k)Nov 3, 2025FDA decision date
Alinity m HCVK252102 · MZPAbbott Molecular, Inc.510(k)Sep 25, 2025FDA decision date
Aptima HCV Quant Dx AssayK233352 · MZPHologic, Inc.510(k)Jul 24, 2024FDA decision date
Alinity m HCV AMP kit, List (REF) Numbers: a) 08N50-095 and b) 08N50-090. The Alinity m HCV assay is an in vitro reverse transcription-polymeras…Z-0407-2024 · MZPAbbott Molecular, Inc.RecallNov 29, 2023FDA classification date
cobas HCVK221007 · MZPRoche Molecular Systems, Inc.510(k)Nov 4, 2022FDA decision date
The Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use.Z-1518-2022 · MZPAbbott Molecular, Inc.RecallAug 12, 2022FDA record creation date
Alinity m System, Part No. 08N53-002Z-0460-2022 · MZPAbbott Molecular, Inc.RecallJan 6, 2022FDA record creation date
Alinity m System, Part No. 08N53-002Z-0461-2022 · MZPAbbott Molecular, Inc.RecallJan 6, 2022FDA record creation date
Alinity m System, Part No. 08N53-002Z-0462-2022 · MZPAbbott Molecular, Inc.RecallJan 6, 2022FDA record creation date
Alinity m System, Part No. 08N53-002Z-0463-2022 · MZPAbbott Molecular, Inc.RecallJan 6, 2022FDA record creation date
COBAS AmpliPrep / COBAS TaqMan HCV Test, US-IVD The COBAS AmpliPrep/COBAS TaqMan HCV Test is an in vitro nucleic acid amplification test for the…Z-2586-2011 · MZPRoche Molecular Systems, Inc.RecallJun 17, 2011FDA classification date
COBAS AmpliPrep / COBAS TaqMan HCV Test, CE-IVD The COBAS AmpliPrep/COBAS TaqMan HCV Test is an in vitro nucleic acid amplification test for the…Z-2587-2011 · MZPRoche Molecular Systems, Inc.RecallJun 17, 2011FDA classification date
Amplilink Software Versions 1.1, 1.3, 1.4, 2.41 COBAS AmpliPrep/COBAS Amplicor HCV Test, version 2.0Z-1107-2007 · MZPRoche Molecular Systems, Inc.RecallAug 2, 2007FDA classification date
Amplicor [3] AV-HRP. (Avidin-HRP (Horseradish Peroxidase) BGG Conjugate.) Kit: Amplicor HCV Detection Kit, v2.0Z-1362-04 · MZPRoche Molecular Systems IncRecallAug 19, 2004FDA classification date
Amplicor [3] AV-HRP, Avidin-HRP (Horseradish Peroxidase) BGG Conjugate. Kit: AmpliCap HCV MonitorTest, Export, RUO.Z-1364-04 · MZPRoche Molecular Systems IncRecallAug 19, 2004FDA classification date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗